[Polyarteritis nodosa and Kawasaki syndrome : Vasculitis predominantly of medium size and small vessels]

Ulrike Sixdorf1, Elisabeth Märker-Hermann2

  • 1Klinik Innere Medizin IV (Geriatrie und Rheumatologie), Helios Dr. Horst Schmidt Kliniken Wiesbaden GmbH, Ludwig Erhard-Str. 100, 65199, Wiesbaden, Deutschland. ulrike.sixdorf@helios-gesundheit.de.

Insights

Polyarteritis nodosa (PAN) and Kawasaki syndrome (KS) are rare medium-vessel vasculitides. Diagnostics involve clinical, angiographic, and histopathological findings, excluding microscopic polyangiitis (MPA) and ANCA.

Area of Science:

  • Rheumatology
  • Pediatric Rheumatology
  • Internal Medicine

Context:

  • Polyarteritis nodosa (PAN) and Kawasaki syndrome (KS) are rare primary vasculitides.
  • These conditions affect medium-sized vessels, as defined by the Chapel Hill Consensus Conference 2012.
  • Unlike microscopic polyangiitis (MPA), PAN and KS do not involve microscopic vessels and are ANCA-negative.

Purpose:

  • To differentiate PAN and KS from other vasculitides.
  • To outline diagnostic criteria for PAN and KS.
  • To present therapeutic strategies for PAN and KS based on disease severity.

Summary:

  • PAN and KS are medium-vessel vasculitides distinct from MPA.
  • Diagnosis relies on clinical presentation, angiography, and exclusion of other conditions; PAN requires histopathology.
  • Treatment approaches for KS in children and PAN in all age groups are discussed.

Impact:

  • Improved understanding of rare vasculitides.
  • Guidance for clinicians in diagnosing and managing PAN and KS.
  • Facilitates tailored treatment strategies for improved patient outcomes.